Qiuhe Ji

7.4k total citations · 1 hit paper
75 papers, 4.2k citations indexed

About

Qiuhe Ji is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Qiuhe Ji has authored 75 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Endocrinology, Diabetes and Metabolism, 24 papers in Molecular Biology and 15 papers in Epidemiology. Recurrent topics in Qiuhe Ji's work include Diabetes Treatment and Management (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Management and Research (19 papers). Qiuhe Ji is often cited by papers focused on Diabetes Treatment and Management (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers) and Diabetes Management and Research (19 papers). Qiuhe Ji collaborates with scholars based in China, United States and Canada. Qiuhe Ji's co-authors include Wenying Yang, Weiping Jia, Zhiguang Zhou, Jianping Weng, Haoming Tian, Zhongyan Shan, Juming Lu, Dalong Zhu, Jiapu Ge and Li Chen and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Qiuhe Ji

73 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Diabetes among Men and Women in China

2010 2.5k citations Wenying Yang, Juming Lu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Qiuhe Ji	2.0k	1.0k	816	636	600	75	4.2k
Juming Lu	2.1k 1.1×	1.0k 1.0×	774 0.9×	492 0.8×	711 1.2×	94	4.3k
Manouchehr Nakhjavani	1.7k 0.8×	913 0.9×	1.1k 1.3×	892 1.4×	568 0.9×	232	4.5k
Jianzhong Xiao	1.6k 0.8×	864 0.9×	716 0.9×	529 0.8×	598 1.0×	63	3.9k
Carlos Lorenzo	2.0k 1.0×	943 0.9×	1.1k 1.3×	1.0k 1.6×	517 0.9×	86	4.1k
Stavroula Α. Paschou	1.6k 0.8×	911 0.9×	637 0.8×	624 1.0×	732 1.2×	200	4.7k
Xuefeng Yu	1.6k 0.8×	766 0.8×	979 1.2×	848 1.3×	585 1.0×	139	4.5k
Dorte Vistisen	2.4k 1.2×	733 0.7×	706 0.9×	822 1.3×	645 1.1×	128	4.3k
Marília Brito Gomes	2.3k 1.1×	798 0.8×	568 0.7×	583 0.9×	739 1.2×	217	4.5k
Ho‐Young Son	1.9k 0.9×	601 0.6×	665 0.8×	540 0.8×	795 1.3×	85	3.7k
Jan Erik Henriksen	1.9k 0.9×	1.3k 1.3×	560 0.7×	843 1.3×	705 1.2×	128	4.6k

Countries citing papers authored by Qiuhe Ji

Since Specialization

Citations

This map shows the geographic impact of Qiuhe Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuhe Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuhe Ji more than expected).

Fields of papers citing papers by Qiuhe Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuhe Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuhe Ji. The network helps show where Qiuhe Ji may publish in the future.

Co-authorship network of co-authors of Qiuhe Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuhe Ji. A scholar is included among the top collaborators of Qiuhe Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuhe Ji. Qiuhe Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Xiaoling, Wen‐Jia Yang, Bo Feng, et al.. (2025). Real-World Multicenter Registry to Determine Management and Quality of Care of Patients with Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases in China (iCaReMe China). Advances in Therapy. 42(3). 1600–1609.

Fu, Jianfang, et al.. (2023). Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study. Journal of Diabetes Research. 2023. 1–10. 8 indexed citations

Liang, Shengru, et al.. (2023). Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men. Postgraduate Medicine. 135(7). 741–749. 18 indexed citations

Hou, Xuhong, Limin Wang, Dalong Zhu, et al.. (2023). Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China. Nature Communications. 14(1). 4296–4296. 65 indexed citations

Ji, Qiuhe, Xingwu Ran, Hongyu Kuang, et al.. (2023). Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China. Diabetes/Metabolism Research and Reviews. 39(8). e3702–e3702. 43 indexed citations

Liu, Jianrong, et al.. (2023). The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial. Journal of Diabetes. 16(2). 3 indexed citations

Fan, Wenqi, Xia Li, Yufei Xiang, et al.. (2022). Distribution of autoantibodies to insulinoma‐associated antigen‐2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross‐sectional study. Diabetes/Metabolism Research and Reviews. 39(2). e3592–e3592. 2 indexed citations

Cheng, Jinxiang, et al.. (2021). Association between Obstructive Sleep Apnea and Type 2 Diabetes Mellitus: A Dose-Response Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 21 indexed citations

Li, Xia, Yufei Xiang, Xiang Yan, et al.. (2021). Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages. Diabetes Technology & Therapeutics. 24(3). 212–219. 6 indexed citations

10.

Yu, Zhi‐Xiang, et al.. (2021). A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma. Scientific Reports. 11(1). 11486–11486. 23 indexed citations

11.

Zhou, Yan, et al.. (2021). Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors. Diabetes Therapy. 12(10). 2677–2690. 2 indexed citations

12.

Wang, Li, Xiangyang Liu, Xinwen Yu, et al.. (2020). Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial. Diabetes Therapy. 11(10). 2313–2328. 4 indexed citations

13.

Tang, Xiao‐Han, Xiang Yan, Hou‐De Zhou, et al.. (2019). <p>Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1527–1541. 29 indexed citations

14.

Jia, Ai‐Qun, Shaoyong Xu, Ying Xing, et al.. (2018). Prevalence and cardiometabolic risks of normal weight obesity in Chinese population: A nationwide study. Nutrition Metabolism and Cardiovascular Diseases. 28(10). 1045–1053. 52 indexed citations

15.

Ma, Xiaoguang, YL Zhang, Qiuhe Ji, et al.. (2017). Diagnostic criteria for diabetes in China: are we pushing too much beyond evidence?. European Journal of Clinical Nutrition. 71(7). 812–815. 2 indexed citations

16.

Guo, Xiaohui, Liming Chen, Qiuhe Ji, et al.. (2016). Effectiveness evaluation of the mobile health patients management mode on treatment compliance and glycemic control for type 2 diabetes patients using basal insulin treatment for 12 weeks. Zhonghua neifenmi daixie zazhi. 32(8). 639–646. 3 indexed citations

17.

Ren, Yanfeng, Nan Jin, Tianpei Hong, et al.. (2016). Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes. Scientific Reports. 6(1). 36437–36437. 16 indexed citations

18.

Xu, Zhangrong, et al.. (2014). Cost-effectiveness of insulin aspart and human soluble insulin for treatment of type 2 diabetes. Zhongguo xin yao zazhi. 23(18). 2174–2179. 1 indexed citations

19.

Ji, Linong, Xinyue Zhi, Juming Lu, et al.. (2014). Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China. PLoS ONE. 9(8). e103507–e103507. 2 indexed citations

20.

Yang, Wenying, Wenhui Zhao, Jianzhong Xiao, et al.. (2012). Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity. PLoS ONE. 7(9). e39513–e39513. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact